Published
A peptide’s reported biological half-life is not its shelf life. A study’s concentration-time finding, a product’s supported storage interval and the date of a laboratory test describe different questions. One cannot supply a missing answer for another.
This guide explains how to read those terms. It does not turn a pharmacokinetic result into a product storage instruction or administration schedule.
What is the difference between half-life, shelf life and a test date?
- Study clock
What happened to the measured concentration in the reported experimental setting?
- Storage clock
Under which conditions and for how long does applicable stability evidence support the specification?
- Test clock
When was the submitted sample analyzed, and what did that record establish?
In a pharmacokinetic discussion, a reported half-life concerns the concentration-time behavior analyzed in that study. It does not describe an unopened bottle merely because the compound has the same name. Likewise, a COA’s analytical date does not automatically establish the remaining storage interval.
Does a long half-life mean a peptide lasts longer in its vial?
No storage conclusion follows from that number alone. Teichman and colleagues reported an estimated CJC-1295 half-life of 5.8–8.1 days in their human investigation. The abstract describes pharmacokinetic and pharmacodynamic research in healthy adults; that figure is not a stability study of a catalog vial. Primary study: Teichman and colleagues, 2006.
The exact material also matters. The CJC-DAC research profile discusses the identity context, while Modified GRF 1-29 has its own profile. Similar store terminology does not justify moving a result between differently specified materials.
For a fictional reading exercise, imagine a paper reporting a time-dependent biological measurement and an unrelated supplier document giving only a test date. The paper cannot fill the supplier document’s missing stability information. Keep two records rather than constructing one combined “lasts this long” claim.
What information actually supports shelf life?
FDA’s explanation of drug expiration dating links the supported period to stability testing and labeled storage conditions. That is context about drug products, not approval of a research listing or a universal interval for every peptide. The useful distinction is that a storage claim needs evidence appropriate to the actual material and conditions. FDA: expiration dates and stability.
Ask which form, formulation, container, conditions and interval the available evidence covers. A dry material and a solution are different records. If no applicable interval is supplied, do not borrow one from another peptide, another seller or a paper studying biological elimination.
| Your question | Relevant record | Insufficient substitute |
|---|---|---|
| What did a human study measure over time? | The study’s exact material, model and pharmacokinetic analysis | A store’s storage note |
| What storage interval is supported? | Applicable stability evidence and conditions | A biological half-life figure |
| What did the lab find on the submitted sample? | The identified report and its test scope | A general research paper |
What should I check before repeating a peptide time estimate?
- Identify which clock the source is describing.
- Retain the exact material, formulation and experimental or storage setting.
- Read whether the number is measured, estimated or proposed.
- Keep qualifications, study limits and any missing information visible.
- Use a separate source for a different question instead of extending the original result.
The CJC-1295 with DAC 5 mg listing is a catalog entry, not the material certificate or stability dataset from the cited investigation. Continue with how to read study evidence and the COA guide when reviewing the separate research and product-documentation questions.
Sources checked October 21, 2026. No universal shelf life or clinical schedule is assigned here.